The addition of ECM-degrading enzymes such as heparanase or relaxin has been proposed [210]; however, during the manufacture of CAR T cells, functional changes that affect heparanase secretion occur, which led to the development of CAR T cells that express HPSE, thus increasing matrix degradation, infiltration, and anti-cancer effects. Here, HPSE is linked to cancer.